N-terminal pro-brain BNP (NT-proBNP) have been extensively studied for their predictive value in patients with heart failure. A systematic review now reveals that BNP is a strong prognostic ...

and brain natriuretic peptide (BNP) are markers of poor outcome in patients with heart failure. To date, most studies of these markers have focused on hospitalized patients with acute ...

An autologous point-of-care cell therapy for adults with ischemic HF with reduced ejection fraction was safe and may be beneficial for select candidates, though a pivotal study did not meet its ...

Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Testing for natriuretic peptide markers, such as B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP), has ...

Whereas obesity is a common confounder when interpreting natriuretic peptide values, and the presence of atrial fibrillation has an important influence on pretest probability, other confounders are ...

There are many hemodynamic effects of BNP which are beneficial in the setting of decompensated congestive heart failure including arterial and venous vasodilation and increased excretion of sodium ...

Heart failure affects about 900,000 people in the UK. It happens when the heart becomes damaged, for example after a heart attack, and cannot pump blood around the body properly. B-type natriuretic ...

Fire1 announced positive results from the first-in-human study of its novel, implantable heart failure (HF) management system ...

Blood tests can also help diagnose systolic heart failure, such as the blood test for B-type natriuretic peptide (BNP), a hormone made by the heart. In people with heart failure, BNP levels are ...

Nagpur: Dr Sunil Gupta, senior diabetologist and founder of the Hello Diabetes Awareness Mission, represented India as ...